Intercept Pharma (ICPT) Gains as Novartis (NVS) Said Interested in Bid
Intercept Pharma (NASDAQ: ICPT) is gaining 5% mid-day on word Novartis (NYSE: NVS) is interested in a takeover of the company in a deal that could be announced in the mid-January, according to a source. In the past, Gilead Sciences (NASDAQ: GILD) was also said to be interested.
The company wasn't available to comment at the time of this publication.